Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.

MLA

Conroy, Samantha, et al. “Unrestricted Faecal Calprotectin Testing Performs Poorly in the Diagnosis of Inflammatory Bowel Disease in Patients in Primary Care.” Journal of Clinical Pathology, vol. 71, no. 4, Apr. 2018, pp. 316–22. EBSCOhost, https://doi.org/10.1136/jclinpath-2017-204506.

APA

Conroy, S., Hale, M. F., Cross, S. S., Swallow, K., Sidhu, R. H., Sargur, R., & Lobo, A. J. (2018). Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care. Journal of Clinical Pathology, 71(4), 316–322. https://doi.org/10.1136/jclinpath-2017-204506

Chicago

Conroy, Samantha, Melissa F Hale, Simon S Cross, Kirsty Swallow, Reena H Sidhu, Ravishankar Sargur, and Alan J Lobo. 2018. “Unrestricted Faecal Calprotectin Testing Performs Poorly in the Diagnosis of Inflammatory Bowel Disease in Patients in Primary Care.” Journal of Clinical Pathology 71 (4): 316–22. doi:10.1136/jclinpath-2017-204506.